Jonas Müntze

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year

Jonas Müntze, Daniel Gensler, Octavian Maniuc et al. · Clinical Pharmacology & Therapeutics · 2018 · 91 citations · Full text

Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS)

Malte Lenders, Peter Nordbeck, Christine Kurschat et al. · Clinical Pharmacology & Therapeutics · 2020 · 65 citations

Treatment of Fabry Disease management with migalastat—outcome from a prospective 24 months observational multicenter study (FAMOUS)

Malte Lenders, Peter Nordbeck, Christine Kurschat et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2021 · 59 citations

α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease

Daniel Oder, Dan Liu, Kai Hu et al. · Circulation Cardiovascular Genetics · 2017 · 38 citations · Full text

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease

Dan Liu, Daniel Oder, Tim Salinger et al. · Open Heart · 2018 · 26 citations · Full text